Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.
In the last several years, global market of Argatroban Industry decreased with the average production growth rate about -15%. In 2015, global capacity of Argatroban reduced to 34786 gramsfrom 65183 grams since 2011. It is predicted that the argatroban demand will continue to decrease with a average growth rate of -9% in the coming five years.Japan is the still largest supplier of argatroban with the production market share of 35% and the consumption market share of 22% in 2015. The price of argatroban is relatively expensive. The largest consumers are developed countries with high income. USA occupied a market share of 34%. The second place is Europe, following North America with the consumption market share of 22% in 2015.China has few companies entering the market with production share of only 8%, and demand cannot be satisfied with supply. Large quantities of argatroban have to be imported.Intially, compared with hirudin and heparin, the therapeutic dose has little effect on platelet, no antigen and strong antithrombotic effect. The sale value has reached 190 million USA dollars in 2008. But because of its narrow therapeutic area, uncertain factors on human’s bodies and fierce competition from other substitutes, it sales far less than other thrombin inhibitor. The value reduced to 101 million USA dollars in 2015.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Argatroban market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Argatroban market. Detailed analysis of key players, along with key growth strategies adopted by Argatroban industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
SANDOZ
Mitsubishi Tanabe Pharma
fresenius-kabi
GlaxoSmithKline Plc
WEST-WARD,INC
Eagle Pharmaceuticals, Inc
Teva Pharmaceutical Industries Ltd
Pfizer, Inc
By Type:
Argatroban Powder
Argatroban Injection
By End-User:
Heparin-induced thrombocytopenia (HIT)
Percutaneous Coronary Intervention
Cerebral arterial thrombosis
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Argatroban Market
-
1.3 Market Segment by Type
-
1.3.1 USA Argatroban Market Size and Growth Rate of Argatroban Powder from 2016 to 2027
-
1.3.2 USA Argatroban Market Size and Growth Rate of Argatroban Injection from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Argatroban Market Size and Growth Rate of Heparin-induced thrombocytopenia (HIT) from 2016 to 2027
-
1.4.2 USA Argatroban Market Size and Growth Rate of Percutaneous Coronary Intervention from 2016 to 2027
-
1.4.3 USA Argatroban Market Size and Growth Rate of Cerebral arterial thrombosis from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Argatroban Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Argatroban Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Argatroban Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Argatroban Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Argatroban Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Argatroban by Major Types
-
3.4.1 Market Size and Growth Rate of Argatroban Powder
-
3.4.2 Market Size and Growth Rate of Argatroban Injection
4 Segmentation of Argatroban Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Argatroban by Major End-Users
-
4.4.1 Market Size and Growth Rate of Argatroban in Heparin-induced thrombocytopenia (HIT)
-
4.4.2 Market Size and Growth Rate of Argatroban in Percutaneous Coronary Intervention
-
4.4.3 Market Size and Growth Rate of Argatroban in Cerebral arterial thrombosis
5 Market Analysis by Regions
-
5.1 USA Argatroban Production Analysis by Regions
-
5.2 USA Argatroban Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Argatroban Landscape Analysis
-
6.1 West USA Argatroban Landscape Analysis by Major Types
-
6.2 West USA Argatroban Landscape Analysis by Major End-Users
7 South USA Argatroban Landscape Analysis
-
7.1 South USA Argatroban Landscape Analysis by Major Types
-
7.2 South USA Argatroban Landscape Analysis by Major End-Users
8 Middle West USA Argatroban Landscape Analysis
-
8.1 Middle West USA Argatroban Landscape Analysis by Major Types
-
8.2 Middle West USA Argatroban Landscape Analysis by Major End-Users
9 Northeast USA Argatroban Landscape Analysis
-
9.1 Northeast USA Argatroban Landscape Analysis by Major Types
-
9.2 Northeast USA Argatroban Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 SANDOZ
-
10.1.1 SANDOZ Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Mitsubishi Tanabe Pharma
-
10.2.1 Mitsubishi Tanabe Pharma Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 fresenius-kabi
-
10.3.1 fresenius-kabi Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 GlaxoSmithKline Plc
-
10.4.1 GlaxoSmithKline Plc Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 WEST-WARD,INC
-
10.5.1 WEST-WARD,INC Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Eagle Pharmaceuticals, Inc
-
10.6.1 Eagle Pharmaceuticals, Inc Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Teva Pharmaceutical Industries Ltd
-
10.7.1 Teva Pharmaceutical Industries Ltd Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Pfizer, Inc
-
10.8.1 Pfizer, Inc Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Argatroban Market Size and Growth Rate of Argatroban Powder from 2016 to 2027
-
Figure USA Argatroban Market Size and Growth Rate of Argatroban Injection from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Argatroban Market Size and Growth Rate of Heparin-induced thrombocytopenia (HIT) from 2016 to 2027
-
Figure USA Argatroban Market Size and Growth Rate of Percutaneous Coronary Intervention from 2016 to 2027
-
Figure USA Argatroban Market Size and Growth Rate of Cerebral arterial thrombosis from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Argatroban Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Argatroban Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Argatroban Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Argatroban Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Argatroban Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Argatroban
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Argatroban by Different Types from 2016 to 2027
-
Table Consumption Share of Argatroban by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Argatroban Powder
-
Figure Market Size and Growth Rate of Argatroban Injection
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Argatroban by Different End-Users from 2016 to 2027
-
Table Consumption Share of Argatroban by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Heparin-induced thrombocytopenia (HIT)
-
Figure Market Size and Growth Rate of Percutaneous Coronary Intervention
-
Figure Market Size and Growth Rate of Cerebral arterial thrombosis
-
Table USA Argatroban Production by Regions
-
Table USA Argatroban Production Share by Regions
-
Figure USA Argatroban Production Share by Regions in 2016
-
Figure USA Argatroban Production Share by Regions in 2021
-
Figure USA Argatroban Production Share by Regions in 2027
-
Table USA Argatroban Consumption by Regions
-
Table USA Argatroban Consumption Share by Regions
-
Figure USA Argatroban Consumption Share by Regions in 2016
-
Figure USA Argatroban Consumption Share by Regions in 2021
-
Figure USA Argatroban Consumption Share by Regions in 2027
-
Table West USA Argatroban Consumption by Types from 2016 to 2027
-
Table West USA Argatroban Consumption Share by Types from 2016 to 2027
-
Figure West USA Argatroban Consumption Share by Types in 2016
-
Figure West USA Argatroban Consumption Share by Types in 2021
-
Figure West USA Argatroban Consumption Share by Types in 2027
-
Table West USA Argatroban Consumption by End-Users from 2016 to 2027
-
Table West USA Argatroban Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Argatroban Consumption Share by End-Users in 2016
-
Figure West USA Argatroban Consumption Share by End-Users in 2021
-
Figure West USA Argatroban Consumption Share by End-Users in 2027
-
Table South USA Argatroban Consumption by Types from 2016 to 2027
-
Table South USA Argatroban Consumption Share by Types from 2016 to 2027
-
Figure South USA Argatroban Consumption Share by Types in 2016
-
Figure South USA Argatroban Consumption Share by Types in 2021
-
Figure South USA Argatroban Consumption Share by Types in 2027
-
Table South USA Argatroban Consumption by End-Users from 2016 to 2027
-
Table South USA Argatroban Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Argatroban Consumption Share by End-Users in 2016
-
Figure South USA Argatroban Consumption Share by End-Users in 2021
-
Figure South USA Argatroban Consumption Share by End-Users in 2027
-
Table Middle West USA Argatroban Consumption by Types from 2016 to 2027
-
Table Middle West USA Argatroban Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Argatroban Consumption Share by Types in 2016
-
Figure Middle West USA Argatroban Consumption Share by Types in 2021
-
Figure Middle West USA Argatroban Consumption Share by Types in 2027
-
Table Middle West USA Argatroban Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Argatroban Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Argatroban Consumption Share by End-Users in 2016
-
Figure Middle West USA Argatroban Consumption Share by End-Users in 2021
-
Figure Middle West USA Argatroban Consumption Share by End-Users in 2027
-
Table Northeast USA Argatroban Consumption by Types from 2016 to 2027
-
Table Northeast USA Argatroban Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Argatroban Consumption Share by Types in 2016
-
Figure Northeast USA Argatroban Consumption Share by Types in 2021
-
Figure Northeast USA Argatroban Consumption Share by Types in 2027
-
Table Northeast USA Argatroban Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Argatroban Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Argatroban Consumption Share by End-Users in 2016
-
Figure Northeast USA Argatroban Consumption Share by End-Users in 2021
-
Figure Northeast USA Argatroban Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of SANDOZ
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of SANDOZ
-
Figure Sales and Growth Rate Analysis of SANDOZ
-
Figure Revenue and Market Share Analysis of SANDOZ
-
Table Product and Service Introduction of SANDOZ
-
Table Company Profile and Development Status of Mitsubishi Tanabe Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mitsubishi Tanabe Pharma
-
Figure Sales and Growth Rate Analysis of Mitsubishi Tanabe Pharma
-
Figure Revenue and Market Share Analysis of Mitsubishi Tanabe Pharma
-
Table Product and Service Introduction of Mitsubishi Tanabe Pharma
-
Table Company Profile and Development Status of fresenius-kabi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of fresenius-kabi
-
Figure Sales and Growth Rate Analysis of fresenius-kabi
-
Figure Revenue and Market Share Analysis of fresenius-kabi
-
Table Product and Service Introduction of fresenius-kabi
-
Table Company Profile and Development Status of GlaxoSmithKline Plc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline Plc
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline Plc
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline Plc
-
Table Product and Service Introduction of GlaxoSmithKline Plc
-
Table Company Profile and Development Status of WEST-WARD,INC
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of WEST-WARD,INC
-
Figure Sales and Growth Rate Analysis of WEST-WARD,INC
-
Figure Revenue and Market Share Analysis of WEST-WARD,INC
-
Table Product and Service Introduction of WEST-WARD,INC
-
Table Company Profile and Development Status of Eagle Pharmaceuticals, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eagle Pharmaceuticals, Inc
-
Figure Sales and Growth Rate Analysis of Eagle Pharmaceuticals, Inc
-
Figure Revenue and Market Share Analysis of Eagle Pharmaceuticals, Inc
-
Table Product and Service Introduction of Eagle Pharmaceuticals, Inc
-
Table Company Profile and Development Status of Teva Pharmaceutical Industries Ltd
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical Industries Ltd
-
Figure Sales and Growth Rate Analysis of Teva Pharmaceutical Industries Ltd
-
Figure Revenue and Market Share Analysis of Teva Pharmaceutical Industries Ltd
-
Table Product and Service Introduction of Teva Pharmaceutical Industries Ltd
-
Table Company Profile and Development Status of Pfizer, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer, Inc
-
Figure Sales and Growth Rate Analysis of Pfizer, Inc
-
Figure Revenue and Market Share Analysis of Pfizer, Inc
-
Table Product and Service Introduction of Pfizer, Inc
-
